CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$79.22
−3.31%Forward multiples
Based on analyst estimates
- P/E forward
- 17.64x
- P/E 2026E
- 37.67x
- P/E 2027E
- 18.59x
- P/E 2028E
- 11.18x
- P/S forward
- 5.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- 52.81x
- PEG TTM
- 0.26x
- Price / book
- 10.40x
- Price / sales
- 9.00x
- Price / cash flow
- 43.76x
Enterprise value
- Enterprise value
- $8.3B
- EV / sales
- 8.62x
- EV / EBITDA
- 65.01x
- EV / EBIT
- 74.91x
- Market cap
- $8.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026